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Summary  Fungal  endocarditis  is  a  relatively  rare  condition  with  particular  difﬁculties  in
diagnosis  and  treatment.  These  difﬁculties  lead  to  higher  rates  of  mortality  and  morbidity.
We  report  the  successful  treatment  of  a  patient  with  rheumatic  mitral  valve  who  had  fungal
endocarditis  due  to  Cushing  syndrome  caused  by  iatrogenic  corticosteroid  supplement.
© 2011  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
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An  18-year-old  man  presented  with  productive  cough,  dys-
pnea,  and  fever  to  the  emergency  department.  Six  months
previously, he  had  been  hospitalized  for  36  days  with  a  diag-
nosis of  pneumonia,  rheumatic  mitral  stenosis,  and  acute
respiratory distress  syndrome.  Three  days  after  discharge
from the  hospital,  the  patient  was  admitted  to  the  same
hospital with  an  itching  eye.  He  had  been  hospitalized  once
more with  the  diagnosis  of  uveitis  and  had  been  given
corticosteroid treatment.  Despite  the  regression  of  uveitis
ﬁndings, the  patient  had  not  improved  and  candida  chori-
oretinitis was  diagnosed.  He  had  been  given  amphotericin  B
and  corticosteroid  treatment  and  had  undergone  vitrectomy.
He had  been  discharged  with  amphotericin  B  and  60  mg/day
prednisolone treatment.
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doi:10.1016/j.jccase.2011.05.007When  he  was  admitted  to  our  hospital  he  had  been  on  cor-
icosteroid treatment  for  almost  four  months.  The  patient
as hospitalized  with  the  diagnosis  of  fever  of  unknown
rigin by  the  infectious  disease  department.  His  physical
xamination revealed  cushingoid  facial  appearance,  diffuse
rritability on  abdomen,  stria  on  abdomen  and  thighs,  and
iny nodules  on  the  palmar  side  of  his  hands.  His  hemoglobin
evel was  6.9  g/dl,  white  blood  cell  count  was  7500/l
nd platelet  count  was  210,000/l.  The  routine  biochem-
cal tests  were  normal  except  a  slight  hyponatremia.  He
ad been  given  an  empiric  antibiotic  treatment  including
azobactam and  ciproﬂoxacin.  Transthoracic  echocardiogra-
hy revealed  mobile,  irregular  dense  bodies  on  both  leaﬂets
f the  ﬁbrotic  mitral  valve.  Transesophageal  echocardiog-
aphy was  performed,  and  we  found  a  7  mm  ×  7  mm  mobile
rregular mass  on  the  anterior  leaﬂet  and  a  10  mm  ×  10  mm
ass on  the  posterior  leaﬂet  which  were  consistent  with
egetation (Fig.  1).  The  patient  was  transferred  to  the  car-
iology department.
At our  department,  teicoplanin  and  amphotericin  were
tarted according  to  suggestions  of  the  infectious  dis-
ase department.  Since  he  had  diffuse  irritability  of  the
Published by Elsevier Ltd. All rights reserved.
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bdomen,  abdominal  computerized  tomography  (CT)  was
erformed. CT  revealed  ﬁndings  which  were  consistent  with
plenic infarction  and  coincident  ileal  invagination.  The
eneral surgery  department  suggested  conservative  man-
gement because  of  the  general  status  of  the  patient.  The
ndocrinology department  suggested  continuation  of  steroid
reatment at  physiologic  doses  to  prevent  an  Addison  cri-
is; and  advised  Addison  protocol  if  emergent  surgery  would
e necessary.  Two  days  later,  the  patient  felt  numbness  of
is right  hand.  Cranial  magnetic  resonance  imaging  ﬁndings
ere consistent  with  septic  emboli  on  both  parietal  lobes
nd small  acute  infarct  areas  on  left  cerebellar,  frontal  and
arietal lobes.  CT  angiography  revealed  aneurysmal  dilata-
ion on  A3  segment  of  the  right  anterior  cerebral  artery
Fig. 2).  The  neurosurgery  department  suggested  conserva-
ive management.  Despite  the  treatment  with  intravenous
eicoplanin, amphotericin  B,  and  ciproﬂoxacin,  the  patient
igure  2  Cerebral  computed  tomography  angiographic  image
f mycotic  aneurysm.
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id  not  improve.  We  repeated  the  transthoracic  and  trans-
sophageal echocardiography  but  we  did  not  ﬁnd  any  change
n vegetation  size.  The  results  of  ﬁve  intermittent  blood
ultures were  negative  as  well  as  the  results  of  urine  cul-
ure. The  patient  had  undergone  mitral  valve  surgery  and
 prosthetic  mitral  valve  had  been  implanted  under  Addi-
on protocol.  The  results  of  tissue  culture  revealed  Candida
pecies. Amphotericin  B  had  been  given  to  the  patient  for  42
ays. The  dosage  of  hydrocortisone  was  decreased  gradually.
he patient  had  recovered  after  42  days  of  amphotericin  B
nd  14  days  of  ciproﬂoxacin  treatment.  Functioning  of  the
rosthetic mitral  valve  was  normal  at  control  echocardiog-
aphy. On  the  ﬁrst  year  control,  the  patient  was  well  with
ood prosthetic  valve  functions.
iscussion
here  is  still  controversy  in  the  diagnosis  and  treatment
f infective  endocarditis.  It  is  hard  to  organize  studies
n infective  endocarditis,  because  the  disease  is  relatively
nfrequent, the  presentation  is  in  a  very  wide  and  unusual
pectrum, causative  agents  are  numerous,  and  risk  factors
or disease  are  extensive  [1].  In  the  diagnosis,  the  Duke  cri-
eria and  especially  the  modiﬁed  Duke  criteria  are  helpful
2,3]. There  are  two  major  problems  in  the  treatment;  ﬁrst  is
he high  mortality  rates  reaching  to  30—80%  in  some  series;
nd the  second  is  the  evidence  of  treatment  is  based  largely
n case  reports,  case  series,  and  expert  opinions  rather  than
arge clinical  trials  [4—6].  For  culture  negative  and  fun-
al endocarditis,  this  issue  becomes  more  apparent.  Most
eports suggest  a  treatment  modality  that  includes  a  wide
pectrum antibiotic  treatment  followed  by  valve  replace-
ent [6,7].  Especially  for  fungal  endocarditis  like  in  our
atient, at  least  6  weeks  of  additional  antifungal  therapy
fter valve  replacement  is  suggested  [8].  In  the  manage-
ent of  endocarditis,  early  diagnosis  and  early  initiation  of
herapy, close  follow  up,  searching  and  the  treatment  of
ossible underlying  conditions,  treatment  of  complications
ung  
[
[
[
[Fungal  endocarditis  involving  rheumatic  mitral  valve  in  a  yo
are  the  cornerstones.  To  our  best  knowledge,  this  is  the  ﬁrst
report of  a  fungal  infective  endocarditis  case  developing  in
a patient  under  steroid  therapy.
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